From Medscape Infectious Diseases

Coverage from the

International Conference on Viral Hepatitis (ICVH) 2016

March 14 - 15, 2016; San Francisco, California

March 14 - 15, 2016 San Francisco, California
  • ICVH Shortened Hep C Combo Passes Real-World Test An 8-week regimen of combination ledipasvir and sofosbuvir appears to clear the hepatitis C virus as well as a 12-week schedule, even in patients with very high viral loads, new research shows.
  • ICVH Opioid Substitutes Do Not Impede Hep C Combo Drugs Outcomes are unaffected in patients with hepatitis C who are treated with opioid substitutes while they are taking the combination of sofosbuvir plus ledipasvir, a new analysis suggests.
  • New Hep C Treatments Cause Adverse Effects in the Elderly Direct-acting antiviral medications effectively clear hepatitis C infection in older patients, but they can also frequently cause unwanted events, researchers warn.

Conference News

Most Popular News from the Last ICVH

Medscape Infectious Diseases©  WebMD, LLC